Covered recipient · General Payments record
LISA ANN BOZIK
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$3,638.73
- Reported across 219 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $261.45 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $78.60 | 5 |
| Lilly USA, LLC | $55.37 | 3 |
| Novo Nordisk AS | $41.89 | 3 |
| Exact Sciences Corporation | $36.24 | 2 |
| PFIZER INC. | $20.96 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $14.55 | 1 |
| Esperion Therapeutics, Inc. | $13.84 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $13.38 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117208471 | CMS |
| Amgen Inc. | $13.27 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117208473 | CMS |
| Amgen Inc. | $19.93 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117208475 | CMS |
| Amgen Inc. | $15.11 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117208477 | CMS |
| Amgen Inc. | $16.91 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117208479 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $14.55 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086158854 | CMS |
| Esperion Therapeutics, Inc. | $13.84 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129456146 | CMS |
| Exact Sciences Corporation | $16.64 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114908257 | CMS |
| Exact Sciences Corporation | $19.60 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114908268 | CMS |
| Lilly USA, LLC | $21.99 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135143879 | CMS |
| Lilly USA, LLC | $17.12 | 04/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135156417 | CMS |
| Lilly USA, LLC | $16.26 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135134212 | CMS |
| Novo Nordisk Inc | $14.51 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096902605 | CMS |
| Novo Nordisk Inc | $13.77 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097734482 | CMS |
| Novo Nordisk Inc | $13.61 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097079384 | CMS |
| PFIZER INC. | $20.96 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131524569 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.